GERMANTOWN, Md. — German company Qiagen is racing to assemble new COVID-19 test kits. Already approved for use in Europe, Qiagen’s new kits are now getting assembled in their North American headquarters in Germantown, Maryland.
The company got the word out through the Germantown-Gaithersburg Chamber of Commerce: It needed temporary workers, all training provided, no degree necessary, to help assemble the new testing kits.
"It does not require a PhD, a master's, or even a bachelor's degree to be intimately involved in this industry," said Richard Bendis, CEO of the non-profit BioHealth Innovation in Rockville.
The FDA says Qiagen’s new test is up for “emergency use authorization.” However, as quick as the test kits can be assembled, the FDA’s normal approval process could take up to three months from now to approve using the kits. The President said Thursday morning some FDA requirements may be relaxed during the crisis.
WUSA9 got the word out on social media about Qiagen's job postings Thursday morning. But by that afternoon, some applicants told WUSA9 they had received automated messages saying the company had all the help it needed.
Qiagen's Robert Reitze told WUSA9 late Thursday afternoon that "the number of applications that we have received has by far outnumbered the available capacity of currently open manufacturing positions. We are very excited about the huge interest of people in Maryland who want to join us in our response efforts to this public health crisis. We want to thank everyone for their applications and will continue to ramp up our production capacities in Germantown to meet a rapidly growing demand for coronavirus testing."
Qiagen did not release the number of open positions nor how many test kits were to be assembled in Germantown.
Bendis believes this hiring surge is a sign that one of the Capital Region’s largest industries is stepping up to the challenge of tackling coronavirus.
"We started referring to it as biohealth about 11 years ago," Bendis said. "The reason for that: it’s not just about biotechnology, like MedImmune and Human Genome sciences which were two of the largest companies that came out of the biotech sector. It’s biopharma. It’s medical devices, It’s bio markers. It’s tools."
Follow our coronavirus reporting
- Why we're closing schools, avoiding events, and suspending the NBA season to stop the coronavirus
- 5 DC-area hospitals have failed infection control inspections since 2018. Here's what that means in the age of coronavirus
- DC restaurants and bars to close to help stop the spread of coronavirus
- '3 months of income wiped out' | Artists are hard hit by "social distancing" period
- How the DMV plans to protect senior citizens, a population at extra risk from coronavirus